0001555280-23-000108.txt : 20230216
0001555280-23-000108.hdr.sgml : 20230216
20230216161849
ACCESSION NUMBER: 0001555280-23-000108
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230214
FILED AS OF DATE: 20230216
DATE AS OF CHANGE: 20230216
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Lagano Roxanne
CENTRAL INDEX KEY: 0001567878
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-35797
FILM NUMBER: 23638741
MAIL ADDRESS:
STREET 1: C/O ZOETIS INC.
STREET 2: 10 SYLVAN WAY
CITY: PARSIPPANY
STATE: NJ
ZIP: 07054
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Zoetis Inc.
CENTRAL INDEX KEY: 0001555280
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 460696167
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 10 SYLVAN WAY
CITY: PARSIPPANY
STATE: NJ
ZIP: 07054
BUSINESS PHONE: 973-822-7000
MAIL ADDRESS:
STREET 1: 10 SYLVAN WAY
CITY: PARSIPPANY
STATE: NJ
ZIP: 07054
4
1
wf-form4_167658231320285.xml
FORM 4
X0306
4
2023-02-14
0
0001555280
Zoetis Inc.
ZTS
0001567878
Lagano Roxanne
C/O ZOETIS INC.
10 SYLVAN WAY
PARSIPPANY
NJ
07054
0
1
0
0
Executive Vice President
Common Stock
2023-02-14
4
M
0
6984
73.24
A
33341
D
Common Stock
2023-02-14
4
M
0
6026
87.51
A
39367
D
Common Stock
2023-02-14
4
S
0
13010
175
D
26357
D
Common Stock
795.7349
I
401(k)
Stock Option
2023-02-14
4
M
0
6984
0
D
Common Stock
6984.0
30585
D
Stock Option
2023-02-14
4
M
0
6026
0
D
Common Stock
6026.0
24559
D
Stock Option
162.07
Common Stock
6542.0
6542
D
The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 25, 2022.
The Price reported in Table I, Column 4 is the price at which these shares were sold in multiple transactions.
Represents the common stock equivalents held in the Zoetis Inc. Savings Plan, a 401(k) plan, as of December 31, 2022.
Stock options (right to buy Zoetis Inc. common stock) granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan.
6,984 options granted February 13, 2018 at an exercise price of $73.24 per option.
Each option vests on the third anniversary of the date of grant.
Each option expires on the tenth anniversary of the date of grant.
2,328 options granted February 13, 2018 at an exercise price of $73.24 per option; 8,036 options granted February 12, 2019 at an exercise price of $87.51 per option; 7,738 options granted February 11, 2020 at an exercise price of $144.03 per option; 7,106 options granted February 10, 2021 at an exercise price of $160.62 per option; and 5,377 options granted February 8, 2022 at an exercise price of $201.30 per option.
6,026 options granted on February 12, 2019 at an exercise price of $87.51 per option.
2,328 options granted February 13, 2018 at an exercise price of $73.24 per option; 2,010 options granted February 12, 2019 at an exercise price of $87.51 per option; 7,738 options granted February 11, 2020 at an exercise price of $144.03 per option; 7,106 options granted February 10, 2021 at an exercise price of $160.62 per option; and 5,377 options granted February 8, 2022 at an exercise price of $201.30 per option.
Stock options (right to buy Zoetis Inc. common stock) granted pursuant to the Zoetis Inc. Amended and Restated 2013 Equity and Incentive Plan.
One-third of each option will vest on the first, second and third anniversaries of the date of grant.
/s/ Brenda Santuccio, as Attorney-in-Fact
2023-02-16